Recent advances in local drug delivery to the inner ear

被引:156
作者
El Kechai, Naila [1 ]
Agnely, Florence [1 ]
Mamelle, Elisabeth [2 ,3 ]
Nguyen, Yann [2 ,3 ]
Ferrary, Evelyne [2 ,3 ]
Bochot, Amelie [1 ]
机构
[1] Univ Paris 11, Fac Pharm, Inst Gallen Paris Sud, CNRS,UMR 8612, F-92290 Chatenay Malabry, France
[2] Univ Paris 06, Sorbonne Univ, Minimally Invas Robot Based Hearing Rehabil, Inserm,UMR S 1159, F-75018 Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Otolaryngol, Unit Otol Auditory Implants & Skull Base Surg, Paris, France
关键词
Cochlea; Hydrogels; Intracochlear administration; Intratympanic administration; Medical drug delivery devices; Nanoparticulate systems; ROUND-WINDOW MEMBRANE; SENSORINEURAL HEARING-LOSS; GUINEA-PIG MODEL; INTRATYMPANIC STEROID-THERAPY; BLOOD-LABYRINTH BARRIER; COCHLEAR IMPLANT; HYALURONIC-ACID; MENIERES-DISEASE; SCALA TYMPANI; CEREBROSPINAL-FLUID;
D O I
10.1016/j.ijpharm.2015.08.015
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Inner ear diseases are not adequately treated by systemic drug administration mainly because of the blood-perilymph barrier that reduces exchanges between plasma and inner ear fluids. Local drug delivery methods including intratympanic and intracochlear administrations are currently developed to treat inner ear disorders more efficiently. Intratympanic administration is minimally invasive but relies on diffusion through middle ear barriers for drug entry into the cochlea, whereas intracochlear administration offers direct access to the colchlea but is rather invasive. A wide range of drug delivery systems or devices were evaluated in research and clinic over the last decade for inner ear applications. In this review, different strategies including medical devices, hydrogels and nanoparticulate systems for intratympanic administration, and cochlear implant coating or advanced medical devices for intracoclear administration were explored with special attention to in vivo studies. This review highlights the promising systems for future clinical applications as well as the current hurdles that remain to be overcome for efficient inner ear therapy. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 101
页数:19
相关论文
共 187 条
[1]
Intratympanic steroid therapy for inner ear diseases, a review of the literature [J].
Alles, M. J. R. C. ;
Gaag, M. A. der ;
Stokroos, R. J. .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (09) :791-797
[2]
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Sousa Lobo, Jose Manuel .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (09) :1223-1237
[3]
Almeida-Branco M.S., 2014, ACTA OTORRINOLARINGO
[4]
Extraneous round window membranes and plugs: Possible effect on intratympanic therapy [J].
Alzamil, KS ;
Linthicum, FH .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2000, 109 (01) :30-32
[5]
Proteocubosomes: Nanoporous vehicles with tertiary organized fluid interfaces [J].
Angelova, A ;
Angelov, B ;
Papahadjopoulos-Sternberg, B ;
Ollivon, M ;
Bourgaux, C .
LANGMUIR, 2005, 21 (09) :4138-4143
[6]
IONIC ENVIRONMENT OF COCHLEAR HAIR-CELLS [J].
ANNIKO, M ;
WROBLEWSKI, R .
HEARING RESEARCH, 1986, 22 (1-3) :279-293
[7]
Cochlear implants and drug delivery: In vitro evaluation of dexamethasone release [J].
Astolfi, Laura ;
Guaran, Valeria ;
Marchetti, Nicola ;
Olivetto, Elena ;
Simoni, Edi ;
Cavazzini, Alberto ;
Jolly, Claude ;
Martini, Alessandro .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2014, 102 (02) :267-273
[8]
Auris medical, 2015, AUR MED PROD CAND
[9]
The role of intracochlear drug delivery devices in the management of inner ear disease [J].
Ayoob, Andrew M. ;
Borenstein, Jeffrey T. .
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (03) :465-479
[10]
Hyaluronan as an ophthalmic viscoelastic device [J].
Balazs, Endre A. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2008, 9 (04) :236-238